International Journal of Nephrology / 2023 / Article / Tab 2 / Research Article
The Impact of Anaemia on Outcomes, Admissions, and Costs in Patients with Chronic Kidney Disease in Two Public Nephrology Practices in Queensland: A CKD.QLD Registry Study Table 2 Anaemia distribution according to baseline characteristics.
No anaemia Mild anaemia Moderate anaemia Severe anaemia N (%)N (%)N (%)N (%)Gender Male 629 (50.2) 397 (64.4) 195 (47.5) 13 (56.5) Female 625 (49.8) 219 (35.5) 215 (52.4) 10 (43.4) Age category <55 years 392 (31.2) 89 (14.4) 62 (15.1) 3 (13.0) 55–64 227 (18.1) 92 (14.9) 72 (17.5) 3 (13.0) 65–74 340 (27.1) 194 (31.4) 103 (25.2) 3 (13.0) >75 295 (23.5) 241 (39.1) 173 (42.2) 14 (60.8) CKD stage Stage 1 149 (11.8) 10 (1.6) 4 (0.9) 0 (0) Stage 2 217 (17.3) 43 (6.9) 6 (1.5) 2 (0.7) Stage 3a 247 (19.7) 82 (13.3) 27 (6.6) 2 (0.7) Stage 3b 384 (30.6) 205 (33.3) 118 (28.8) 3 (13.0) Stage 4 230 (18.3) 217 (35.2) 178 (43.4) 11 (47.8) Stage 5 27 (2.1) 59 (9.6) 77 (18.8) 5 (21.7) Primary renal diagnosis (PRD) RVD† 333 (26.6) 183 (29.7) 117 (28.5) 6 (26.1) DN‡ 213 (16.9) 152 (24.7) 129 (31.5) 7 (30.4) GN§ 187 (14.9) 81 (13.1) 33 (8.0) 4 (17.4) GRD¶ 91 (7.3) 23 (3.7) 12 (2.9) 0 (0) Other 258 (20.6) 109 (17.7) 70 (17.1) 3 (13.0) Uncertain 172 (13.7) 68 (11.0) 49 (11.9) 3 (13.0)
† RVD: renovascular disease; ‡ DN: diabetic nephropathy; § GN: glomerulonephritis; ¶ GRD: genetic renal disease.